SCHEMBL13927744

SCHEMBL13927744

Cc1ccc(C)c(C(=O)NC(C)C(C)C)c1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.56
UTS2R Q9UKP6 1/20 0.47
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HSD17B10 Q99714 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
TAS1R3 Q7RTX0 3/20 0.41
TAS1R1 Q7RTX1 3/20 0.41
TAS1R2 Q8TE23 3/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
CTSV O60911 1/20 0.41
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
NPC1 O15118 1/20 0.40
ABCB1 P08183 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24571408 0.83 TAS1R3 (0.46) POLBTAS1R3TAS1R1TAS1R2
SCHEMBL4171511 0.79 POLB (0.52) POLBUTS2RLMNASMN1; SMN2HSD17B10
SCHEMBL24571390 0.79 HPGD (0.53) POLBLMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL24567577 0.79 HPGD (0.53) POLBLMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL14872913 0.76 CA1 (0.39) POLBLMNATAS1R3TAS1R1TAS1R2
SCHEMBL4175755 0.76 TAS1R3 (0.53) LMNATAS1R3TAS1R1TAS1R2HPGD
SCHEMBL4166757 0.76 TAS1R3 (0.53) LMNATAS1R3TAS1R1TAS1R2HPGD
SCHEMBL4766299 0.76 SMN1; SMN2 (0.57) POLBUTS2RLMNASMN1; SMN2HSD17B10
SCHEMBL13407497 0.74 SMN1; SMN2 (0.55) POLBUTS2RSMN1; SMN2HSD17B10MEN1
SCHEMBL4169088 0.74 SMN1; SMN2 (0.61) LMNASMN1; SMN2MEN1KMT2ATAS1R3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers DEWIS MARK L 2009-02-19 US disclosed
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers DEWIS MARK L 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers TAS2R10, TAS2R50, TAS2R8 POLB 4329/4885UTS2R 1338/4885LMNA 3147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.